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Supporting Information 
 
Chemicals and Materials   
All solvents and salts purchased from commercial sources were used as received unless 
otherwise stated. Tris(hydroxymethyl)aminomethane (Tris base) was obtained from Fisher 
Scientific. Poly(dimethylsiloxane) (PDMS, Sylgard 184 Silicone Elastomer kit) was obtained 
from Dow Corning. FC-84 (perfluoroheptane), FC-40 (a mixture of perfluoro-tri-n-butylamine 
and perfluoro-di-n-butylmethylamine), and FC-70 (Perfluoro- tri-n-pentylamine) were obtained 
from 3M. Teflon capillaries (OD 250 m, ID 200 m and OD 150 M, ID 50 M) were received 
from Zeus Inc. Thirty-gauge Teflon tubing was obtained from Weico Wire & Cable. Gastight 
syringes were obtained from Hamilton Company. 6-histidine-tagged reaction center (hRC) from 
Rhodobacter sphaeroides was generously provided by Phil Laible of Argonne National Lab. A 
peptide of 10 histidines tagged with fluorescein (His10) was purchased from Anaspec. 6-
histidine-tagged streptavidin (hSA) was purchased from ProSpec-Tany TechnoGene Ltd.  
 
RfOEG synthesis 
The synthesis is based on previously published methods.1 Triethylene glycol (Acros, MW: 
150.17) was dried over molecular sieves and 1 equivalent was added to a dried round bottom 
flask with a stir bar. 1.5 equivalents of CF3(CF2)7CH2OH (Sigma-Aldrich, MW: 450.1) and 1.3 
equivalents of 1,1’-azodicarbonyldipiperidine (ADDP) (TCI, MW: 252.31) were also added to 
the flask. These were dissolved in anhydrous benzene (Sigma-Aldrich), so that concentrations 
wee around 0.1 M. The reaction mixture was then stirred and heated to ~ 60 C. Then 1.4 
equivalents of tributylphosphine (Sigma-Aldrich, MW: 202.32) were added to benzene (about 
half the volume that was added to the round bottom flask) by using an addition funnel. This 
solution was then slowly added to the reaction mixture over 1-2 hours.  Once addition was 
complete, the mixture was heated for an additional 3 hours, or until color was lost. Upon cooling, 
a significant amount of precipitant formed. The precipitant was filtered off, and the solvent was 
removed by rotary-evaporation. Next, the crude product was rinsed and filtered with cold ethyl 
acetate, the solvent was removed by rotary-evaporation, and the process was repeated in cold 
methanol to remove all solid impurities. The product was then purified by using column 
chromatography and fluorous chromatography (Fluorous Technologies). Spectral data: 1H NMR 
(CDCl3) : 3.98 (t, 2H), 3.74 (t, 2H), 3.67 (t, 2H), 3.62 (m, 6H), 3.55 (t, 2H), 3.0 (b, 1H); 13C 
NMR (CDCl3) : 120-105, 72.65, 72.44, 70.86, 70.64, 70.43, 68.35 (t, J = 100 Hz), 61. 73. 
Electrospray mass spectrometry in positive mode showed a single peak at 583.0 m/z 
corresponding to [RFOEG + H+]+. 
 
RfNTA synthesis 
Scheme S1 shows the synthetic route to RfNTA (4) 
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Synthesis of RfOEG(6) (1) 
Hexaethylene glycol (Sigma-Aldrich, MW: 282.33) was dried over molecular sieves and 1 
equivalent was added to a dried round bottom flask with stir bar.  2.5 equivalents of 
CF3(CF2)7CH2OH (Sigma-Aldrich, MW: 450.1) and 1.5 equivalents of 1,1’-
azodicarbonyldipiperidine (ADDP) (TCI, MW: 252.31) were also added to the flask. These were 
dissolved in anhydrous benzene (so that concentrations were around 0.1 M). The reaction 
mixture was then stirred at room temperature. Next, 1.6 equivalents of tributylphosphine (Sigma-
Aldrich, MW: 202.32) were dissolved in benzene (about half the volume that was added to the 
round bottom flask) by using an addition funnel. This solution was then slowly added to the 
reaction mixture over 3-4 hours, and the reaction was allowed to run overnight. Next, the 
precipitant was filtered off, and the solvent was removed by rotary-evaporation. The crude 
product was then rinsed and filtered with cold ethyl acetate, the solvent was removed by rotary-
evaporation, and the process was repeated in cold methanol to remove all solid impurities. The 
product (1) was then further purified by using column chromatography and fluorous 
chromatography. Spectral data: 1H NMR (CDCl3) : 4.02 (t, 2H), 3.74 (t, 2H), 3.68 (t, 2H), 3.61 
(m, 18H), 3.56 (t, 2H), 3.0 (b, 1H); 13C NMR (CDCl3) : 120-105, 72.65, 72.37, 70.76, 70.72, 
70.67-70.59, 70.37, 68.33 (t, J = 100 Hz), 61.73. Electrospray mass spectrometry in positive 
mode showed a single peak at 715.0 m/z corresponding to [(1) + H+]+.   
 
Synthesis of (2) 
2 equivalents of 1,1’-carbonyldiimidazole (Sigma-Aldrich, MW: 162.15) were dissolved in dry 
methylene chloride (Fisher). (1) (MW: 714.41) was also dissolved in dry methylene chloride and 
added slowly to the 1,1’-carbonyldiimidazole. The reaction was stirred overnight at room 
temperature under dry nitrogen.  The product (2) was purified by using column chromatography. 
Spectral data: 1H NMR (CD3OD) : 8.33 (s, 1H), 7.63 (s, 1H), 7.09 (s, 1H), 4.1 (t, 2H), 3.88, (m, 
2H), 3.78 (m, 2H), 3.61 (m, 20H), 2.0 (b, 1H). 
 
Synthesis of RfNTA (4) 
10 equivalents of 1,8-Diazabicyclo[5.4.0]undec-7-ene (Acros, MW: 152.24) and 1 equivalent of 
N,N-Bis(carboxymethyl)-L-lysine trifluoroacetate salt (3) (Sigma-Aldrich, MW:376.3) were 
suspended in dry methylene chloride. Next (2) (MW: 808.5) was dissolved in methylene chloride 
and added to the reaction mixture, and then the reaction was stirred overnight at room 
temperature under dry nitrogen. The solvent was then removed and the remaining solid was 
washed several times with ethyl acetate. Next, the solid was dissolved in a minimal amount of 
methanol (Fisher) and sodium isopropylphenoxide (prepared by mixing sodium methoxide 
(Acros) with a slight excess of isopropylphenol (Sigma-Aldrich)) was added. The mixture was 
stirred for 15 minutes, and any solid was filtered off. Next, the liquid was evaporated, the solid 
was dissolved in a minimal amount of methanol, and the product was precipitated using ether 
(Fisher). The product (4) (MW= 1068.6) was then further purified by using fluorous 
chromatography. Spectral data: 1H NMR (CD3OD) : 4.1 (m, 4H), 3.7 (m, 5H), 3.61 (m, 22H), 
3.10 (m, 2H), 2.0-1.5 (m, 6H); 13C NMR (CDCl3) : 158.94, 129.93, 73.165, 71.49-71.28, 70.85, 
69.31, 68.97 (t, J:= 100 Hz), 64.85, 56.86, 41.28, 30.52, 28.43, 25,48. Electrospray mass 
spectrometry in negative mode showed a predominant peak at 1000.8 m/z, and an additional 
peak at 1023.8 m/z consistent with [RfNTA-3Na++2H+]- salt and [RfNTA-2Na++H+]- 
respectively. 
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Characterization 
1H and 13C NMR were acquired on Bruker Avance DRX 400MHz or Bruker Avance III 500MHz 
spectrometers (Bruker BioSpin). ESI-MS were acquired from Agilent 1100 LC/MSD with ESI or 
APCI ion sources (Agilent Technologies). 
 
PDMS Device Fabrication.  
Poly(dimethylsiloxane) (PDMS) was used to fabricate all microfluidic devices. Microchannels 
with rectangular cross-sections were fabricated with rapid prototyping.2 The hybrid microfluidic 
devices consisted of PDMS microchannels (cross-section: 250 m by 250 m) with three or four 
tapered inlets (100 m by 250 m) for aqueous phases and one orthogonal inlet for carrier fluid 
to form plugs of nanoliter volumes. The channel walls were functionalized with 
(tridecafluoro1,1,2,2-tetrahydrooctyl)-1-trichlorosilane (United Chemical Technologies) to 
render them hydrophobic and fluorophilic.3 Teflon tubing was inserted into the outlet up to the 
junction at which plugs formed. The tubing was sealed to the device with either wax or PDMS 
glue (Dow-Corning Sylgard). 
 
Interfacial adsorption experiments using hGFP 
Microfluidic devices with three aqueous-inlets were used to perform interfacial adsorption 
experiments. In these experiments, the left aqueous stream contained the additive solution, which 
was either 1) 100 mM Tris, pH 7.0, 2) 115 M NiSO4 in 100 mM Tris, pH 7.0, 3) 125 M 
RfNTA in 100 mM Tris, pH 7.0, 4) 125 M (3) and 115 M NiSO4 in 100 mM Tris, pH 7.0, or 
5) 62.5 M RfNTA and 57.5 M NiSO4 in 100 mM Tris, pH 7.0. The stock buffer solution had 
been pretreated with chelex to remove any divalent cations, and all other solutions were made 
from this stock solution. When mixed with RfNTA, the concentration of Ni2+ was always 
between 90-95% of the RfNTA concentration to ensure that no free Ni2+ was left in solution. 
Higher concentrations of RfNTA:Ni were also tested and performed similarly. The center stream 
always contained 100 mM Tris, pH 7.0, except for the experiment with 20 mM EDTA (Fisher) in 
100 mM Tris, pH 7.0.  The right stream contained 2 M hGFP (Upstate, now part of Millipore) 
and 0.25% lauryldimethylamine N-oxide (LDAO) (Anatrace) (w/v) in 100 mM Tris, pH 7.0.  
Plugs were formed in Teflon tubing (OD 150 m, ID 50 m) using FC-40 that had been pre-
equilibrated with 20 mM EDTA. The carrier fluid was flowed at a rate of 8.3-16.67 nL/sec, by 
using PHD2000 syringe pumps (Harvard Apparatus).  No additional surfactant was used in the 
FC-40, except when 0.25 mg/mL RfOEG (MW 582.25) was used. The hGFP always flowed at a 
rate of 3.33 nL/sec, so the final concentration was 400 nM hGFP and 0.05% LDAO. The other 
two flow rates were adjusted so that the total aqueous flow rate was always 16.67 nL/sec. The 
additive and buffer flow rates were both 6.67 nL/sec for additive conditions 1-4, so the final 
concentrations were 46 M Ni2+, 50 M RfNTA, and 50 M (3) and 46 M Ni2+, for conditions 
2-4 respectively. For condition 5, the flow rates were 3.33 and 10 nL/sec for the additive and 
buffer stream, respectively, leading to final concentrations of 12.5 M RfNTA and 11.5 M 
Ni2+. When EDTA was added to the buffer stream, it gave a final concentration of 12 mM 
EDTA. Plugs were formed for at least 2 minutes, after which flow was stopped, and then the 
tubing was cut, and the ends of the tubing were sealed onto a glass slide with wax. For imaging 
the tubing was submerged in milliQ-H2O.  Bright field and fluorescence images were obtained 
by using confocal microscopy on a Leica DMI6000 microscope (Leica Microsystems) using a 
VT-Infinity 3 confocal scanning head (VisiTech international). Images were analyzed using 
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SimplePCI software (Hammamatsu Corp.) and MetaMorph 6.3 (Molecular Devices).  See Figure 
1e-g and Figure S2. 
 
FRAP experiments 
Plugs were formed as described above. The final concentration of His10 was 3.7 M in 20 mM 
Tris pH 8.0. The final RfNTA:Ni concentration was 30 M RfNTA and 28.5 M Ni. Plugs were 
formed in three different fluorocarbons: FC-70 with a viscosity of 12 cSt, FC-40 with a viscosity 
of 1.8 cSt, and FC-84 with a viscosity of 0.53 cSt at room temperature.  All fluorocarbons 
contained 170 M RfOEG to prevent nonspecific adsorption. 
During the FRAP experiments 10 images of the edges of a plug were obtained before 
bleaching. Next, spots were bleached on the edges of the plugs using high laser power for 2 
seconds, and the regions were then monitored for an additional 40 seconds. Linescans spanning 
the edges of the plugs were used to monitor fluorescence recovery at the plug interface over 
time. The shape of the bleach spot was fit using Origin 8 (OriginLab) to the Gaussian curve 
described by Equation 1. A generalized solution to Fick’s second law of diffusion is given in 
Equation 2 and draws obvious parallels to Equation 1.4  
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I is intensity, I0 is the initial intensity, A(t) is the maximum amplitude at time t, x is the 
position, and x0 is the offset, and w determines the distribution width of the curve.  C is the 
concentration, C0 is the initial concentration. M is the total amount of the diffusing species, D is 
the diffusion coefficient, r is the position, and t is time. 
 Monitoring the change in the shape of the Gaussian over the time course of recovery 
allows for extraction of a diffusion coefficient and requires no predetermined knowledge of the 
geometry of the bleach spot or of the diffusion dimension.4 From Equations 1 and 2 it can be 
seen that w2 = 2*D*t, so plotting w2 vs. t should give a straight line with slope 2*D. The 
diffusion dimension can be determined using log A(t) = -d/2* log (t) + K. 
 This analysis gave diffusion coefficients of 7.3 ± 2.6 x 10-12 m2/sec, 15.2 ± 2.4 x 10-12 
m2/sec, 39.2 ± 11.5 x 10-12 m2/sec for FC-70, FC-40 and FC-84 respectively (Figure S4 and 
Table S1). In all cases there was basically complete recovery of fluorescence indicating that no 
immobile phase existed. The measured diffusion dimension was 1.1 ± .3, 1.1 ± .2, 2.0 ± .4 for 
FC-70, FC-40 and FC-84 respectively (Table S1).  However, due to the log-log plot, the 
accuracy of d is greatly affected by the time range in which reliable data can be obtained. 
Divalent metals are capable of quenching fluorescein, and significant quenching was observed 
when using His10.  This led to fairly noisy data, which limited the timescale over which accurate 
measurements could be obtained (Figure S3). Analysis including later time points than those 
shown in Figure S4 indicated that d for FC-70 was likely accurate; whereas d for FC-40 fell 
between 1 and 2, and d for FC-84 remains near 2. This general trend of increasing diffusion 
dimension with faster diffusion can be explained if the geometry of the bleaching zone is 
considered. The bleaching zone is not a point; rather, there is a cone above and below the focal 
plane. If the bleaching zone of the laser above and below the focal plane is large compared to the 
length scale of diffusion, then the predicted diffusion dimension would be 1, as recovery can 
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only come from fluorophore in the focal plane. On the other hand, for faster diffusion, the 
diffusion dimension would approach 2 as fluorophores above and below the plane could 
contribute. 
 Similar experiments were performed with hGFP at 1 M, and fluorescein-labeled hSA at 
250 nM. The hGFP could not be analyzed in the same fashion due to a quenching effect that 
resulted in a temporary enhancement of fluorescence around the bleach spot during recovery 
(Figure S5). Rough estimates of D0, obtained by fitting fluorescence recovery of the area 
surrounding the bleach spot with a single exponential curve, were approximately 3 x 10-12 m2/sec 
for FC-40 and 30 M RfNTA:Ni. For the labeled hSA interfacial binding was weak, possibly 
due to the close proximity of the his-tag to structural components of the protein.  However, initial 
experiments resulted in D0 using the Gaussian fitting model of 4.5 ± 0.6 and 9.2 ± 2.4 x 10-12 
m2/sec for FC-70 and FC-40, respectively (Table S1).  It makes sense that the hGFP and hSA 
give slower diffusion than His10, as a protein would create more drag than a small peptide.  
However the D0 for a protein in solution is around 1 x 10-10 m2/sec, so events at the interface still 
dominate the diffusion rather than the attached protein or peptide. 
FRAP was measured using a Leica tandem scanner SP5 spectral confocal on a DMI6000 
microscope with a 40x NA1.40 oil objective. Images were analyzed by using ImageJ software 
and the plug-in loci bio-formats and by using Mathematica.  See Figures 1h, S3, S4, S5 and 
Table S1. 
 
Tensiometry 
Droplets of the solution of fluorous surfactant were formed at the end of disposable droplet 
extrusion tips. The tips were assembled by using quick-set epoxy to glue polyimide-coated glass 
tubing into 1-10L disposable pipet tips that were oxidized in a Plasma Prep II plasma cleaner 
(SPI Supplies) for 1.5 minutes to render them hydrophilic. The end of the capillary was 
positioned just inside the end of the pipet tip. The polyimide tubing was connected to a 50 L 
Hamilton Gastight syringe by using 30-gauge Teflon tubing. The syringe was then filled with the 
fluorous solution. The pipette tip was positioned so that it sat in the aqueous solution within a 1 
mL polystyrene cuvette, and the tip was held in place by a clamp. The formed droplets were 
imaged using Model 250 Standard Digital Goniometer & DROPimage Advanced software 
(Rame-Hart Instrument Co).  See Figure S1. 
 
Crystallization of his-tagged reaction center (hRC). For each of the six different additive 
conditions, two sets of 40 individual crystallization trials were set up for each of the five 
precipitant concentrations. Four-aqueous-inlet devices were used to perform crystallization 
experiments. In sequence, the precipitant stream was 50% (w/v) PEG 4000, 1.1 M NaCl, 9% 
(w/v) 1,2,3-heptanetriol (HPT) in 50 mM Tris pH 7.8. The buffer stream was 9% HPT in 50 mM 
Tris pH 7.8. The additive stream used six different solutions in six different sets of experiments, 
and they were 1) 10 mM Tris pH 7.8, which was defined as the standard condition, 2) 45 M 
NiSO4 in 10 mM Tris pH 7.8, 3) 50 M RfNTA in 10 mM Tris pH 7.8, 4) 50 M RfNTA and 45 
M NiSO4 in 10 mM Tris pH 7.8, 5) 200 M RfNTA and 180 M NiSO4 in 10 mM Tris pH 7.8, 
and 6) 200 M RfNTA and 180 M NiSO4 and 10 mM imidazole in 10 mM Tris pH 7.8. The 
protein stream was 6 mg/mL hRC from Rhodobacter sphaeroides in 0.05% (w/v) LDAO and 10 
mM Tris pH 7.8. The fluorinated carrier fluid was FC-40. The carrier fluid, protein, and additive 
streams were maintained at constant flow rates of 41.7 nL/sec, 13.3 nL/sec and 3.3 nL/sec, 
respectively.  The flow rate of the precipitant stream was first increased from 8.3 nL/sec to 15 
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nL/sec, and then decreased from 15 nL/sec to 8.3 nL/sec, with a step size of 1.7 nL/sec.  
Correspondingly, the buffer stream was first decreased from 8.3 nL/s to 1.7 nL/sec, and then 
increased from 1.7 nL/sec to 8.3 nL/sec, with a step size of 1.7 nL/sec. Each flow rate step lasted 
for 14 s.  After one step was finished, the subroutine was stopped and, ~5 s later, it was restarted 
with the setup of the next step. In this experiment, two sets of plugs generated from identical 
flow rates were counted as duplicates. The experiments were performed six times with six 
different additive solutions. The trials, in the form of plugs, were transported and stored in 
Teflon tubing (O.D.: 250 m and I.D.: 200 m) which was sealed inside glass tubing (O.D.: 3 
mm and I.D.: 1.8 mm) prefilled with FC-70. The experiment was performed under dim light, and 
the trials were kept in the dark at 23 oC. 
The following final precipitant concentrations were obtained: 0.45 × [ppt]= 22.5% (w/v) PEG 
4000, 0.495 M NaCl, 4.5% (w/v) 1,2,3-heptanetriol (HPT) in 30 mM Tris pH 7.8, 0.4 × [ppt]= 
20% (w/v) PEG 4000, 0.44 M NaCl, 4.5% (w/v) 1,2,3-heptanetriol (HPT) in 30 mM Tris pH 7.8, 
0.35 × [ppt]= 17.5% (w/v) PEG 4000, 0.385 M NaCl, 4.5% (w/v) 1,2,3-heptanetriol (HPT) in 30 
mM Tris pH 7.8, 0.3 × [ppt]= 15% (w/v) PEG 4000, 0.33 M NaCl, 4.5% (w/v) 1,2,3-heptanetriol 
(HPT) in 30 mM Tris pH 7.8, 0.25 × [ppt]= 12.5% (w/v) PEG 4000, 0.275 M NaCl, 4.5% (w/v) 
1,2,3-heptanetriol (HPT) in 30 mM Tris pH 7.8. Because the behavior of crystallization can be 
different depending on the purity of samples, the experiment was performed twice with different 
protein preparations made months apart, and similar results were obtained both times. To avoid 
spurious results from background levels of divalent metals such as those observed for condition 
3, low levels of a chelating agent such as EDTA could be added to the crystallization conditions. 
The data presented in this paper is from the current purification protocol performed by Phil 
Laible of Argonne National Lab. 
 
Counting plugs with crystals. Counting of plugs was performed under dim light, at day 1, day 
2, day 5, and day 12 after setting up the experiments. In all experiments for each flow rate step, 
40 plugs were counted, starting from the tenth plug of each set. Plugs with crystals were counted 
as one hit. To make sure we did not start from different plugs on different days, we took a picture 
of the first counted plug in each set of plugs.     
 
Determining the nucleation rate. The nucleation rate was determined for different additive 
conditions at two precipitant concentrations: 1) 0.40 × [ppt] where plugs of crystallization trials 
were formed at 13.3 nL/sec and 2) 0.45 × [ppt] where plugs of crystallization trials were formed 
at 15 nL/sec. 0.40. In 1) finalconcentrations of precipitant were 20% (w/v) PEG 4000, 0.44 M 
NaCl and 30 mM Tris pH 7.8, whereas in 2) final concentrations of precipitant were 22.5% (w/v) 
PEG 4000, 0.5 M NaCl and 30 mM Tris pH 7.8. To determine the nucleation rate for each 
concentration of precipitant, the percentage of the number of plugs with crystals out of the total 
number of counted plugs (40 in all cases) was plotted against the recording time (days) (Figure 
S6). The nucleation rate was then extracted from the slope of the plots, determined by dividing 
the change in the number of plugs with crystals by the change in time. The nucleation rate was 
equal to the largest slope for each curve. If no crystals were obtained over time, the nucleation 
rate was zero. All the nucleation rates were extracted from day 0 to day 1 except the one for the 
standard condition at 0.45 × [ppt], which was extracted from day 0 to day 5. The nucleation rates 
were plotted in a histogram in Figure 2b. 
 In our experiments, we counted the number of plugs instead of the number of crystals. 
For standard conditions, there was always only one crystal per plug, whereas many of the other 
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conditions often had multiple crystals per plug. Because the number of individual nucleation 
events was not counted, the calculated nucleation rates represent the lower limit of the actual 
nucleation rate. 
 
Crystal preparation and X-ray Data Collection. Cryo-protectant for freezing hRC crystals was 
25% (v/v) PEG 400, 20% (w/v) PEG 4000, 0.44 M NaCl in 0.08% (w/v) LDAO and 20 mM Tris 
pH 7.8.  Crystals of hRC from R. sphaeroides grown in the plugs were extracted by attaching a 
syringe to one end of the Teflon tubing and flowing the crystals slowly into a drop of cryo-
protectant by using the manual syringe driver.5  Once crystals were flowed into a 2 L drop of 
cryo-protectant, the crystals were picked up with a CryoLoop (Hampton Research) and flash 
frozen in liquid nitrogen. The X-ray diffraction experiments were performed at GM/CA Cat 
station 23 ID-B of the Advanced Photon Source (Argonne National Laboratory). In all 
experiments, the wavelength was kept at 1.03 Å. We used a 10 m minibeam and set the 
attenuation at five. The exposure time was kept at 10 seconds. The data were processed in 
HKL20006 to determine space group and diffraction limit with S/N over 2.0. The best diffraction 
limits for different additive conditions are listed in Table S2. Figure S8 shows some 
representative diffraction patterns. 
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Scheme S1:  Synthesis of RfNTA. 
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Figure S1:  Surface tension measurements of RfOEG and RfNTA alone (red and blue, 
respectively) and together (green). They coexist at the interface, as indicated by the observation 
that the surface tension of the combined system is lower than either component individually. 
 
 
 
Figure S2:  No interfacial adsorption occurs with (a) just Ni2+ or (b) just RfNTA. (c) There is 
also no interfacial adsorption when NTA, with no fluorous tail, + Ni2+ is added. (d) The addition 
of EDTA to an RfNTA:Ni system also prevents any interfacial adsorption by binding up all the 
Ni2+. 
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Figure S3:  Data and Gaussian fits for images shown in Figure 1h a) from immediately after 
bleaching, b) from 2 seconds after bleaching and c) from 5 seconds after bleaching. 
 
 
 
Figure S4:  Plot of w2 vs t from the Gaussian fits of the FRAP data obtained for His10 when the 
fluorocarbon used was FC-84 (red squares), FC-40 (blue circles) and FC-70 (green triangles). 
The slope of the fit of these lines was used to determine D0. 
 
 
Figure S5:  Fluorescence recovery of plugs containing 1 M hGFP and 30 M RfNTA:Ni 
surrounded by fluorocarbons of different viscosities. The temporary fluorescence enhancement 
shown here would not allow for proper fits to a Gaussian curve, but the recovery rate still shows 
a dependence on the fluorocarbon used. 
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 His10 hSA 
Fluoro
carbon 
D0 
(m2/sec) 
Error 
(m2/sec) d Error 
D0 
(m2/sec) 
Error 
(m2/sec) d Error 
FC-84 39.2 x10-12 11.5 x10-12 2.0 0.4 - - - - 
FC-40 15.2 x10-12 2.4 x10-12 1.1 0.2 9.2 x10-12 2.4 x10-12 1.0 0.1 
FC-70 7.3 x10-12 2.6 x10-12 1.1 0.3 4.5 x10-12 0.6 x10-12 0.8 0.2 
Table S1: Diffusion coefficients and diffusion dimension obtained from FRAP experiments 
using His10 and hSA. The error represents the 95% confidence interval. 
 
 
 
Figure S6: The increase in the number of plugs with crystals of hRC over time. Six different 
additive conditions were plotted at two precipitant concentrations, 0.4 × [ppt] (left) and 0.45 × 
[ppt] (right)respectively. The nucleation rates were extracted from the plots and represented in 
Figure 2b. 
 
 
 
Figure S7:  At lower precipitant concentrations (0.35 × [ppt]; 17.5% (w/v) PEG 4000, 0.385 M 
NaCl, 4.5% (w/v) 1,2,3-heptanetriol (HPT) in 30 mM Tris pH 7.8) hRC crystals were only 
obtained upon addition of the RfNTA:Ni complex (top row of images). 
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Condition X-ray diffraction 
resolution 
Frames collected 
(0.5 o/frame) Mosaicity 
Crystal 1 4Å 2 4.0 Standard/45% ppt Crystal 2 6 Å 2 2.9 
Crystal 1 4.5 Å 1 N/A 50 m RfNTA /40% 
ppt Crystal 2 6 Å 5 6.0 
Crystal 1 4 Å 18 1.2 50 m RfNTA /45% 
ppt Crystal 2 5 Å 2 3 
Crystal 1 13 Å 1 N/A 50 m RfNTA:Ni/35% 
ppt Crystal 2 18 Å 1 N/A 
Crystal 1 3.7 Å 1 N/A 50 m RfNTA:Ni 
/40% ppt Crystal 2 4 Å 1 N/A 
Crystal 1 3.5 Å 18 3.1 50 m RfNTA:Ni 
/45% ppt Crystal 2 3.7 Å 1 N/A 
Crystal 1 18 Å 1 N/A 200 m RfNTA:Ni 
/30% ppt Crystal 2 20 Å 1 N/A 
Crystal 1 3.5 Å 16 2.0 200 m RfNTA:Ni 
/35% ppt Crystal 2 3.5 Å 2 4.0 
Crystal 1 3.1 Å 48 2.5 200 m RfNTA:Ni 
/40% ppt Crystal 2 4 Å 14 2.8 
Crystal 1 over 20 Å 1 N/A 200 m RfNTA:Ni 
/45% ppt Crystal 2 over 25 Å 1 N/A 
200 m RfNTA:Ni + 
imidazole/30% ppt Crystal 1 7 Å 1 N/A 
Crystal 1 6 Å 1 N/A 200 m RfNTA:Ni + 
imidazole /35% ppt Crystal 2 7 Å 1 N/A 
Crystal 1 3.7 Å 20 3.8 200 m RfNTA:Ni + 
imidazole /40% ppt Crystal 2 8 Å 1 N/A 
200 m RfNTA:Ni + 
imidazole /45% ppt Crystal 1 3.5 Å 18 2.4 
Table S2: Summary of X-ray diffraction of crystals of hRC in different additive conditions.  
Data were obtained from two crystals at most conditions 
 
 
Figure S8: X-ray diffraction of hRC crytals grown in different additive conditions. 
a) Crystals from 200 m RfNTA:Ni at 0.4 × [ppt] diffracted best to 3.1 Å ; b) Crystals from the 
standard condition at 0.45 × [ppt] diffracted best to 4 Å and c) Crystals from 50 M RfNTA at 
0.45 × [ppt] diffracted best to 4 Å. 
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